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Summary.-Zinc, testosterone and dihydrotestosterone concentrations have been
measured in normal prostatic tissue and in specimens obtained from untreated
patients with benign prostatic hyperplasia (BPH) and carcinoma of the prostate
(CaP). The metal-androgen relationship was examined and related to the patho-
logical condition of the patients.
The evidence suggests that discriminant analysis combining the hormonal data
into a single variable is a reliable test for distinguishing between BPH and CaP
patients. We have observed that the high Zn values found in BPH specimens were
always associated with a DTH :T ratio >1. Androgen tissue ratios <1 were charac-
teristic of all CaP specimens, and these were usually preceded by a reduction in pros-
tatic Zn concentration. Since these patterns, particularly those associated with neo-
plasia, precede the clinical manifestations, they may be used as an index for pre-
dicting the onset of carcinoma in the prostate gland. They may also be of value in
monitoring the progress of the disease.
THE DEVELOPAIENT of neoplasia is
generally accepted to be a multi-stage
phenomenon. First the cell undergoes a
series of qualitative and quantitative
changes which progressively assume a
permanent and irreversible character
(Foulds, 1958). Some biochemical aspects
of the development of carcinoma occur
at an early stage, long before neoplasia
becomes histologically evident. These
might be the first indication of the
presence of a cancer and could, therefore,
assist in tumour detection.
Recognition ofcarcinoma ofthe prostate
depends at present on the discovery at
rectal examination of a palpable abnor-
mality in the prostate, or on the histo-
logical finding of malignancy in prostatic
tissue after surgery to relieve bladder
obstruction. These methods are, however,
of no value as a screening tool for early
malignancy.
O(ie recognized biochemnical feature of
carcinoma of the prostate is the low Zn
concentration in the malignant tissue
compared with the hypertrophied or
normal gland (Gyorkey et al., 1967; Habib
et al., ] 976a). A second biochemical feature
is the elevated level of prostatic tissue
testosterone levels in carcinoma compared
with benign hypertrophy (Habib et al.,
1976b). These metal and hormonal dif-
ferences in normal and pathological con-
ditions have not, however, always been
evident. Indeed, a number ofinvestigators
have reported a degree ofoverlap between
the various groups (Schrodt et al., 1964;
Geller et al., 1978). Recent in vitro studies
have revealed, however, that the concen-
tration of Zn in prostatic cells influences
androgen metabolism, on which prostatic
growth and function depend (Grant et al.,
1l975; Habib, 1978). In the present in-
vestigation we have therefore used dis-
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crimniiianit anialyses to combine the hor-
monal data into a single variable. Analyses
of the relationship between this variable
and the Zn content of the prostatic tissue
suggest a new approach for the detection
of prostatic cancer. The outcome of these
studies is described in this report.
PATIENTS AND METHODS
P'atients.-Prostatic specimens (20-40 mg
dry wt) w-ere obtained by transurethral
resection from 10 patients aged 64-91 (mean
73) years with carcinoma of the prostate
(CaP), and 20 patients aged 58-87 (mean 70)
years with benign prostatic hyperplasia
(BPH). No patient had received any treat-
iient for at least 1 monith before the study.
Following the removal of blood by wvashing
the tissue x 3 with cold 0 90O NaCl solution,
the specimens were frozen in liquid N2 and
stored at -25°C. Before freezing the chips
wvere bisected and one half retained for
histological examination to confirm the
diagnosis. Normal necropsy specimens (age
range 40-59 years) were also obtained Awithin
11 h of death, and frozen after cleaning.
Although the prostates from most males over
50 years have evidence of hyperplasia, for the
purpose of this study the prostates were con-
sidered to be normal, provided that the
patient had no urinary symptoms and the
histology revealed the absence of significant
abnormalities.
The assays were performed within 3 weeks
of sample collection.
Zinc estimation. Zn Awas determined by
flame atomic-absorption spectrophotometry
(Perkin-Elmer 30) using a modification of the
method described by Dawson & Walker
(1969). Specific details of the procedure have
already been reported (Habib et al., 1976a).
Endogenous steroid levels.-Testosterone
(T) and dihydrotestosterone (DHT) wAere
measured by radioimmunoassay. after a
single separation on a celite column, using an
antiserum against testosterone-3-(O-carboxy-
inethyl) oxime-bovine-seruimi-all)umiii coIn-
jugate. Details of the extraction, chromato-
graphic separation, radioimmunoassay and
reliability of the method have been described
(Habib et al., 1976b).
RESULTS
Analyses were performed inore than 3
years ago, after transurethral resection:
we have therefore had an opportunity for
a 3-year follow-up (1974-77) in each in-
stance. During that period, only 3 patients
of the original number were lost to the
follow-up.
The androgen and Zn concentrations in
these specimens were compared with those
in normal tissues (Table). The levels of T
in CaP were significantly higher than in
either BPH or normal tissue (P<001).
DHT, however, was significantly higher in
BPH than in normal samples (P<001),
intermediate values being found in CaP.
These results suggest a high 5cx-reductase
activity in the hypertrophied gland; the
DHT:T ratios in the 3 conditions are
compared in the Table.
The data in the Table also suggest that
Zn is present in about equal concentra-
tions in adult normal and hyperplastic
prostates. The average concentration of
Zn in CaP (194 /Lg/g dry tissue) is, how-
ever, considerably lower (P<0 01) than
the mean value in the BPH samples
(460 jug/g) and in normal specimens (517
vg/g). There is nonetheless an apparent
degree ofoverlap between the values found
in the benign and malignant prostates.
This overlap is caused by an unusual
depression in the Zn levels of 5 of the
diagnosed BPH specimens and, as dis-
cussed below, is an important marker of
potential diagnostic value.
Further analysis of the androgen data
TABLE.-Zinc and androgen levels in nornial and pathological prostates
Zn (/Lglg (Iry wvt)
A
Mean -_- s.e. Range
517 51 121-1136
460± 53 131-900
1944-19 112-342
Testosterone
(ng/g dIry Nvt)
Mean 4 se. Range
287-' 0-49 1-13-7-17
3-23±0-47 1-14-12-7
10-60- 1-62 5-53-18-8
Dihydrotestosterone
(ng/g dry wt t)
Mlean-- s.e. Range
2-99±0-*36 1-18-5.35
10-5 1-31 3-92-35.00
6-06-4-074 2 30-9-16
Type of
specimen*
(No. patients)
Normal (8)
BPH (20)
CaP (10)
DHT
T
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FiG. 1. Comparison of the concentrations of testosterone and dihyclrotestosterone in tissue from
patients with benign prostatic hypertrophy (BPH; 0) and carcinoma of the prostate (CaP; A).
Regression lines are shown with correlation coefficients (r).
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Fie. 2. The relationship between the ratio DHT: T and Zn concentrations in the tissue of 15 patients
with BHP (-), 10 patients with CaP (A) and 5 BHP patients that subsequently became CaP (x).
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(Fig. 1) reveals a strong positive correla-
tion between T and DHT in the hyper-
plastic (r 0-82, P<0 01) and in the neo-
plastic specimens (r 0-768, P<0 01). No
similar relationship was detected in nor-
mal tissues.
The present results also suggest an
association between the ratio DHT:T
and tissue Zn concentration in the BPH
and CaP samples (Fig. 2). DHT:T was,
in all BHP cases, >1b0 and usually asso-
ciated with a Zn concentration in excess
of 350 ,ug/g of dry tissue. The dramatic
change in the steroid composition of the
malignant prostate accounts for the sud-
den fall in the prostatic androgen tissue
ratios seen in all the examined neoplastic
specimens, the DHT:T ratio in CaP being
always <1 0. Depletion of Zn concentra-
tions to levels much lower than 350 lug/g
was another distinct feature of the car-
cinomatous tissue. Although a critical
demarcation line exists between the can-
cerous and hyperplastic specimens (Fig. 2),
some of the early studies revealed the
presence of 5 BPH samples with androgen
ratios >1I 0, but, with their Zn levels
within the malignant range (<350 ,ug/g).
To account for these depressed Zn values
we have followed the clinical progress of
these 5 patients along with the other 15
BPH patients examined in this study. Four
of the 5 with low Zn levels but normal
DHT:T ratios subsequently developed a
histologically proven carcinoma of the
prostate. No records were available on the
fifth patient. The remaining 15 biochemic-
ally confirmed BPH patients (i.e. those
with DHT:T >1 and zinc >350 pg/g)
maintained their pathological status.
D)ISCUSSION
These results indicate that androgen
and Zn relationships may be used as an
index for the onset of neoplasia in the
prostate gland.
The T, DHT and Zn assays were chosen
because they had been previously shown
to give the best biochemical discrimina-
tion between hyperplastic and neoplastic
tissue (Gyorkey et al., 1967; Habib et al.,
1976a, b) and because they can be easily
and rapidly performed. Discriminant
analysis was used to combine the hormonal
data into a single variable which is clearly
superior to the individual tests at separat-
ing BPH and CaP patients, as shown in
Figs. 1 and 2.
Our results (Fig. 2) also showed a strong
correlation between the Zn and the DHT
ratios in tissue. High Zn levels are always
associated with DHT:T ratio >10,
whereas a ratio < I 0 is characterized by a
reduction in Zn concentration. This
strongly suggested that the endocrine
status of the gland and its Zn content are
interrelated and reflect the clinical con-
ditions.
We have repeatedly demonstrated that
Zn concentrations in CaP are <350 ,tg/g,
whereas in BPH specimens their levels
were always greater than 350 pg/g. It was
therefore concluded that the biochemical
classification of a tissue as hyperplastic
was only acceptable provided that the
DHT:T> 1 and that theZn concentrations
exceeded 350 vg/g; the converse applies
to CaP.
Although most patients in the present
study belonged to either pathological
state, we were confronted by a group of 5
patients with DHT:T in the hyperplastic
range while their Zn levels indicated
malignant characteristics (Zn <350 /g/g).
This 3rd group created scepticism as to
the potential relationship of the Zn-
androgen axis to the pathological condi-
tion of the patient. However, subsequent
biopsy on 4 ofthese 5 patients, recalled for
a variety of reasons, established the pre-
sence of histological carcinoma in each.
Unfortunately, we were unable to find the
records ofthe fifth patient, but the follow-
up studies on the 15 other BPH patients
revealed no marked changes in their clini-
cal condition.
These findings support the view that the
development of neoplasia in the prostate
is a multi-stage phenomenon. The gland
undergoes a number of biochemical chan-
ges: the reduction ofZn concentration and
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a complete shift in the hormonal status of
the prostate are apparent, possibly before
neoplasia becomes histologically evident.
We have recently demonstrated that
Zn ions inhibit androgen metabolism in the
prostate (Habib, 1978). The results re-
ported in this paper also indicate that the
hormonal changes in the tissue were
manifested only after the Zn concentra-
tions had reached physiologically sub-
normal levels. Since these biochemical
changes may precede the histological
transformation, perhaps clinicians should
consider the possibility of using these
biochemical measurements as a diagnostic
test for predicting the onset of carcinoma,
and in support of information from histo-
logical examination. These measurements
might also be of value in monitoring the
treatment of patients with malignant
prostates.
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